清肺理痰方通过调节肠道菌群与短链脂肪酸代谢改善急性肺损伤小鼠的作用机制

    Mechanism of Qingfei Litan Formula in Improving Acute Lung Injury in Mice by Regulating Gut Microbiota and Short-chain Fatty Acids Metabolism

    • 摘要:
      目的  分析急性肺损伤(acute lung injury,ALI)小鼠的肠道菌群特点及清肺理痰方的干预效果,探讨肠道菌群变化与肺部炎症、氧化应激、短链脂肪酸(short-chain fatty acids,SCFAs)代谢之间的相关性,以揭示清肺理痰方的作用机制。
      方法 不同剂量清肺理痰方预防给药后进行脂多糖(lipopolysaccharide,LPS)气管滴注建立ALI小鼠模型,24 h后安乐死并检测小鼠支气管肺泡灌洗液(broncho-alveolar lavage fluid,BALF)中炎性细胞数目和炎症因子水平,观察肺组织病理变化,计算肺系数及肺湿/干比,检测肺组织氧化应激指标的表达水平、血清中SCFAs的含量,进行肠道菌群16S rRNA高通量测序并分析。
      结果 清肺理痰方干预能减轻ALI小鼠的肺泡损伤及肺水肿,降低BALF中炎性细胞数目、炎症因子水平,减少肺组织中的丙二醛含量,提高超氧化物歧化酶和谷胱甘肽过氧化物酶活性,提高血液中SCFAs的含量。肠道菌群分析结果显示,清肺理痰方能提升肠道菌群的Alpha多样性,增加有益菌Lachnospiraceae NK4A136、LactobacillusPrevotellaceae UCG-001、Prevotellaceae NK3B31、Ruminiclostridium 6、EnterorhabdusRuminococcaceae UCG-013,减少有害菌AlloprevotellaErysipelatoclostridiumPeptococcus属水平上的相对丰度。相关性分析显示,7个有益菌属的相对丰度肺部炎症和氧化应激水平均呈负相关,与血液中乙酸、丙酸、丁酸含量均呈正相关,其中仅3个有益菌与戊酸含量呈正相关;有害菌属的相关性则相反。此外,乙酸、丙酸、丁酸与BALF中炎症因子及氧化应激水平均呈负相关,戊酸仅与BALF中炎症因子(IL6、IL-1β)水平呈负相关。
      结论 清肺理痰方可能通过调节肠道菌群结构及SCFAs代谢,发挥抗炎和抗氧化应激的作用,保护ALI小鼠肺组织。

       

      Abstract:
      OBJECTIVE  To analyze the characteristics of gut microbiota in mice with acute lung injury(ALI) and the intervention effect of Qingfei Litan formula, to explore the correlation between changes in gut microbiota and lung inflammation, oxidative stress, and short-chain fatty acids(SCFAs) metabolism, thereby revealing the mechanism of action of Qingfei Litan formula.
      METHODS  The ALI mouse model was established via lipopolysaccharide(LPS) tracheal instillation after administering different doses of Qingfei Litan formula. After euthanasia, inflammatory cells and factors in broncho-alveolar lavage fluid(BALF) examined lung pathology were evaluated, the lung coefficient and wet/dry ratio were calculated, oxidative stress markers in lung tissues were assessed, SCFAs content in serum were measured, and 16S rRNA sequencing of the intestinal microbiota were conducted.
      RESULTS  Qingfei Litan formula alleviated alveolar damage and pulmonary edema in ALI mice, reduced inflammatory cells and factors in BALF, decreased malondialdehyde in lung tissue, increased superoxide dismutase and glutathione peroxidase activities, and elevated SCFAs in blood. It enhanced gut microbiota Alpha diversity, increased the relative abundance of beneficial bacteria like Lachnospiraceae NK4A136, Lactobacillus, Prevotellaceae UCG-001, Prevotellaceae NK3B31, Ruminiclostridium 6, Enterorhabdus, Ruminococcaceae UCG-013, and decreased harmful bacteria like Alloprevotella, Erysipelatoclostridium, Peptococcus. Correlation analysis revealed that the relative abundances of seven beneficial bacterial genera exhibited negative correlations with both pulmonary inflammation and oxidative stress levels, while showing positive correlations with the contents of acetate, propionate, and butyrate in the blood. Among these, only three beneficial bacterial genera demonstrated positive correlations with valerate content. Conversely, harmful bacterial genera showed opposite correlation patterns. Additionally, acetate, propionate, and butyrate were negatively correlated with inflammatory cytokines and oxidative stress levels in BALF, whereas valerate was only negatively correlated with the levels of inflammatory cytokines(IL-6, IL-1β) in BALF.
      CONCLUSION Qingfei Litan formula may exert anti-inflammatory and anti-oxidative stress effects by regulating gut microbiota and SCFAs metabolism, thereby protecting lung tissue in acute lung injury mice.

       

    /

    返回文章
    返回